An observational study in Hemolytic Anemia, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-27.
Sponsored by Sohag University · Observational
the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases.
And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.
56 studies on the registry are indexed under Anemia, Hemolytic; 16 are open to participants now.
This study's planned enrollment of 60 is close to the median of 56 across 16 observational studies indexed under Anemia, Hemolytic.
Browse Anemia, Hemolytic studies →Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients admitted in Internal Medicine department and Intermediate care unit at sohag university hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
blood samples for CBC parameters , peripheral blood smear, bilirubin levels and kidney function tests
intensive care unit admission of the patients due to progression of the disease complications.
Primary outcome will be ICU admission due to progression of the disease complications.
Time frame: through study completion, an average of 6 months
mortality within duration of hospital admission
Secondary outcome will be mortality within duration of hospital admission
Time frame: through study completion, an average of 6 months
Start is estimated for Dec 2024; primary completion for Jun 2025, 6 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.